NCT06766773

Brief Summary

The composite warming strategy has a certain effect on preventing hypothermia during cancer liver resection surgery. This study aims to explore the application of compound warming strategy in perioperative nursing of cancer liver resection. This study will compare two groups: the control group using perioperative forced warming measures, and the experimental group using a composite warming strategy. Main objective: Intraoperative temperature changes Secondary objective: incidence of complications The investigators' investigated the practicality and effectiveness of a combined warming strategy in open liver resection surgery. In addition, the investigators also conducted a quantitative correlation study on the incidence of hypothermia during the surgical process. This provides evidence-based guidance for the prevention of hypothermia during surgery.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
5 years until next milestone

First Submitted

Initial submission to the registry

January 4, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 9, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 10, 2025

Status Verified

January 1, 2025

Enrollment Period

5.9 years

First QC Date

January 4, 2025

Last Update Submit

January 9, 2025

Conditions

Keywords

Intraoperative hypothermiaOpen hepatectomy for liver cancerComposite warming strategy

Outcome Measures

Primary Outcomes (1)

  • Intraoperative temperature changes

    Intraoperative temperature changes: After the surgery begins, a temperature monitoring device (disposable medical temperature sensor provided by the limited company) is inserted into the patient's nasopharynx to record the core temperature, while activating the water blanket and forced air.

    At the beginning of the surgery; every 5 minutes during surgery; after the surgery is completed.

Study Arms (2)

Control group: perioperative mandatory warming measures

PLACEBO COMPARATOR
Procedure: perioperative mandatory warming measures

Compound heating strategy

EXPERIMENTAL
Procedure: Compound heating strategy

Interventions

After the surgery begins, a temperature monitoring device (disposable medical temperature sensor provided by the limited company) is inserted into the patient's nasopharynx to record the core temperature, while activating the water blanket and forced air heating system.

Compound heating strategy

perioperative mandatory warming measures

Control group: perioperative mandatory warming measures

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 18 and 75 years.
  • Scheduled for elective open hepatectomy to treat hepatocellular carcinoma, confirmed by preoperative biopsy or imaging.
  • Adequate liver function (Child-Pugh score A or B).
  • American Society of Anesthesiologists (ASA) physical status classification of I, II, or well-controlled III.
  • Informed consent provided for participation.

You may not qualify if:

  • Aged under 18 or over 75 years.
  • Metastatic liver disease or emergency liver surgery required.
  • Chronic analgesic use that could interfere with pain assessment.
  • Participation in another clinical trial within the past 30 days.
  • Contraindications to warming devices (e.g., certain skin conditions or advanced peripheral vascular disease).
  • Pregnant or lactating.
  • Presence of an implantable device (e.g., pacemakers or defibrillators) that could be affected by warming strategies.
  • Cognitive impairment or psychiatric disorders affecting study understanding or informed consent.
  • Use of medications/substances impacting thermoregulation (e.g., illicit drugs, alcohol abuse, antipyretics).
  • History of malignancies other than liver cancer affecting survival or perioperative risk.
  • Recent history (within six months) of myocardial infarction or cerebrovascular accident.
  • Uncontrolled diabetes mellitus or other significant endocrine disorders.
  • Severe anemia (hemoglobin below a predetermined threshold).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First People's Hospital of Neijiang

Neijiang, Sichuan, 641000, China

Location

Related Publications (11)

  • John M, Ford J, Harper M. Peri-operative warming devices: performance and clinical application. Anaesthesia. 2014 Jun;69(6):623-38. doi: 10.1111/anae.12626. Epub 2014 Apr 10.

    PMID: 24720346BACKGROUND
  • Andrzejowski J, Hoyle J, Eapen G, Turnbull D. Effect of prewarming on post-induction core temperature and the incidence of inadvertent perioperative hypothermia in patients undergoing general anaesthesia. Br J Anaesth. 2008 Nov;101(5):627-31. doi: 10.1093/bja/aen272. Epub 2008 Sep 26.

    PMID: 18820248BACKGROUND
  • Kvolik S, Jukic M, Matijevic M, Marjanovic K, Glavas-Obrovac L. An overview of coagulation disorders in cancer patients. Surg Oncol. 2010 Mar;19(1):e33-46. doi: 10.1016/j.suronc.2009.03.008. Epub 2009 Apr 25.

    PMID: 19394816BACKGROUND
  • Kanikarla Marie P, Fowlkes NW, Afshar-Kharghan V, Martch SL, Sorokin A, Shen JP, Morris VK, Dasari A, You N, Sood AK, Overman MJ, Kopetz S, Menter DG. The Provocative Roles of Platelets in Liver Disease and Cancer. Front Oncol. 2021 Jul 21;11:643815. doi: 10.3389/fonc.2021.643815. eCollection 2021.

    PMID: 34367949BACKGROUND
  • Staikou C, Paraskeva A, Drakos E, Anastassopoulou I, Papaioannou E, Donta I, Kontos M. Impact of graded hypothermia on coagulation and fibrinolysis. J Surg Res. 2011 May 1;167(1):125-30. doi: 10.1016/j.jss.2009.07.037. Epub 2009 Aug 26.

    PMID: 19932906BACKGROUND
  • Birgin E, Kaslow SR, Hetjens S, Correa-Gallego C, Rahbari NN. Minimally Invasive versus Open Liver Resection for Stage I/II Hepatocellular Carcinoma. Cancers (Basel). 2021 Sep 25;13(19):4800. doi: 10.3390/cancers13194800.

    PMID: 34638285BACKGROUND
  • Xu H, Xu G, Ren C, Liu L, Wei L. Effect of forced-air warming system in prevention of postoperative hypothermia in elderly patients: A Prospective controlled trial. Medicine (Baltimore). 2019 May;98(22):e15895. doi: 10.1097/MD.0000000000015895.

    PMID: 31145350BACKGROUND
  • Simegn GD, Bayable SD, Fetene MB. Prevention and management of perioperative hypothermia in adult elective surgical patients: A systematic review. Ann Med Surg (Lond). 2021 Nov 14;72:103059. doi: 10.1016/j.amsu.2021.103059. eCollection 2021 Dec.

    PMID: 34840773BACKGROUND
  • Diaz M, Becker DE. Thermoregulation: physiological and clinical considerations during sedation and general anesthesia. Anesth Prog. 2010 Spring;57(1):25-32; quiz 33-4. doi: 10.2344/0003-3006-57.1.25.

    PMID: 20331336BACKGROUND
  • Balki I, Khan JS, Staibano P, Duceppe E, Bessissow A, Sloan EN, Morley EE, Thompson AN, Devereaux B, Rojas C, Rojas C, Siddiqui N, Sessler DI, Devereaux PJ. Effect of Perioperative Active Body Surface Warming Systems on Analgesic and Clinical Outcomes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Anesth Analg. 2020 Nov;131(5):1430-1443. doi: 10.1213/ANE.0000000000005145.

    PMID: 33079867BACKGROUND
  • Yi N, Wang Z, Cui R. Warming with a composite warming strategy reduces intraoperative hypothermia in patients undergoing open hepatectomy for liver cancer: A randomized controlled study. Medicine (Baltimore). 2025 Feb 21;104(8):e41616. doi: 10.1097/MD.0000000000041616.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Cancer Center

Study Record Dates

First Submitted

January 4, 2025

First Posted

January 9, 2025

Study Start

January 1, 2020

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

January 10, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations